- Home
- DERM vs VBF Comparison
DERM vs VBF Comparison
Compare DERM & VBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- VBF
- Stock Information
- Founded
- DERM 2014
- VBF 1970
- Country
- DERM United States
- VBF United States
- Employees
- DERM N/A
- VBF N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- VBF Trusts Except Educational Religious and Charitable
- Sector
- DERM Health Care
- VBF Finance
- Exchange
- DERM Nasdaq
- VBF Nasdaq
- Market Cap
- DERM 213.6M
- VBF 177.8M
- IPO Year
- DERM 2021
- VBF N/A
- Fundamental
- Price
- DERM $7.92
- VBF $15.46
- Analyst Decision
- DERM Strong Buy
- VBF
- Analyst Count
- DERM 3
- VBF 0
- Target Price
- DERM $12.67
- VBF N/A
- AVG Volume (30 Days)
- DERM 256.5K
- VBF 45.5K
- Earning Date
- DERM 11-12-2025
- VBF 01-01-0001
- Dividend Yield
- DERM N/A
- VBF 5.18%
- EPS Growth
- DERM N/A
- VBF N/A
- EPS
- DERM N/A
- VBF N/A
- Revenue
- DERM $59,399,000.00
- VBF N/A
- Revenue This Year
- DERM $26.16
- VBF N/A
- Revenue Next Year
- DERM $45.27
- VBF N/A
- P/E Ratio
- DERM N/A
- VBF N/A
- Revenue Growth
- DERM 2.82
- VBF N/A
- 52 Week Low
- DERM $3.54
- VBF $13.68
- 52 Week High
- DERM $9.40
- VBF $16.27
- Technical
- Relative Strength Index (RSI)
- DERM 48.07
- VBF 38.08
- Support Level
- DERM $7.42
- VBF $15.52
- Resistance Level
- DERM $9.40
- VBF $15.68
- Average True Range (ATR)
- DERM 0.54
- VBF 0.15
- MACD
- DERM -0.14
- VBF -0.02
- Stochastic Oscillator
- DERM 27.53
- VBF 13.59
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About VBF Invesco Bond Fund
Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.